Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.
about
Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operativRecent advances in the management of AL Amyloidosis.Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
P2860
Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Auto-SCT improves survival in ...... alysis with 14-year follow-up.
@en
Auto-SCT improves survival in ...... alysis with 14-year follow-up.
@nl
type
label
Auto-SCT improves survival in ...... alysis with 14-year follow-up.
@en
Auto-SCT improves survival in ...... alysis with 14-year follow-up.
@nl
prefLabel
Auto-SCT improves survival in ...... alysis with 14-year follow-up.
@en
Auto-SCT improves survival in ...... alysis with 14-year follow-up.
@nl
P2093
P2860
P356
P1476
Auto-SCT improves survival in ...... alysis with 14-year follow-up.
@en
P2093
M H Qazilbash
R Champlin
R Z Orlowski
S A Giralt
P2860
P2888
P304
P356
10.1038/BMT.2014.115
P407
P577
2014-06-02T00:00:00Z